Nayak S
Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Dr, Baltimore, MD, 21224, USA.
ArticlePsilocybin
Psilocybin-induced neurocardiogenic syncope: a case report.
ArticlePsilocybin
Psychedelic medicine: mechanisms, evidence, and translation to practice.
ArticlePsilocybin
Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals.
ArticlePsilocybin
Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.
ArticlePsilocybin
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.
ArticlePsilocybin
IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.
ArticlePsilocybin
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.
ArticlePsilocybin
Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.
ArticlePsilocybin
Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.
PreprintPsilocybin